Zhejiang Ausun is an API manufacturer based in China. It holds 8 valid CEPs across a filed portfolio of 13 molecules. Its GMP standing is certified by EMA.
| Site | FDA FEI |
|---|---|
| Taizhou, China | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Ticagrelor | EDQM, SFDA (Saudi Arabia) | 4 |
| Entecavir | EDQM, SFDA (Saudi Arabia) | 3 |
| Apixaban | SFDA (Saudi Arabia) | 2 |
| Febuxostat | SFDA (Saudi Arabia) | 2 |
| Sugammadex | SFDA (Saudi Arabia) | 2 |
| Entecavir Monohydrate | EDQM | 1 |
| Imatinib Mesilate | EDQM | 1 |
| Latanoprost | EDQM | 1 |
| Macitentan | SFDA (Saudi Arabia) | 1 |
| Nebivolol | EDQM | 1 |
| Pilocarpine | EDQM | 1 |
| Posaconazole | SFDA (Saudi Arabia) | 1 |
| Tofacitinib | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Zhejiang Ausun comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.